insights_auto
Why is RHHBF down 4,07%?
Dive Deeperchevron_right
RHHBF:OTCMKTS
Roche Holding AG
441,30 USD
arrow_downward
-4,07%(-18,70) 1D
15-окт., 10:00:17 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RHHBF...
Open
441,30 USD
High
441,30 USD
Low
441,30 USD
Mkt. cap
371,21 млд
Avg. vol.
63,00
Volume
5,00
P/E ratio
191,72
52-wk high
514,08 USD
52-wk low
301,27 USD
EPS
2,30 USD
Beta
0,45
Shares outstanding
106,69 млн
No. of employees
113 миң
Open
441,30 USD
High
441,30 USD
Low
441,30 USD
Mkt. cap
371,21 млд
Avg. vol.
63,00
Volume
5,00
P/E ratio
191,72
52-wk high
514,08 USD
52-wk low
301,27 USD
EPS
2,30 USD
Beta
0,45
Shares outstanding
106,69 млн
No. of employees
113 миң
News stories
From web sources and news partners
TipRanks
·
1 күн мурун
Nurix Therapeutics’ High-Stakes Reliance on Roche: Cost Burdens, Control Risks and Uncertain Returns for Lead Drug Bexobrutideg
Reuters
·
2 күн мурун
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
Euronext Markets: Real-time Stock Market Data | live
·
2 күн мурун
Roche strikes obesity drug licensing deal worth up to $1.16 billion with Chinese Rona Therapeutics
ad-hoc-news.de
·
2 күн мурун
Roche Holding stock rises 3.44 percent on SIX
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG
CEOThomas Schinecker
Employees113 миң
Founded1896-ж., 1-окт.
HeadquartersБазель, Базель-Штадт, Швейцария
SectorPharmaceutical industry
Websiteroche.com